期刊文献+

CD40与慢性特发性血小板减少性紫癜免疫发病机制关系的初步研究 被引量:1

The effect of CD40 on the pathogenesis of chronic idiopathic thrombocytopenic purpura
暂未订购
导出
摘要 目的:了解慢性特发性血小板减少性紫癜(CITP)患者骨髓、血液中B淋巴细胞协同刺激因子CD40的表达情况,从而进一步了解CITP的免疫学发病机制。方法:采用流式细胞术检测CITP患者的骨髓及末梢血的淋巴细胞协同刺激因子CD40的表达,并用ELISA方法检测血液中的PAIgG。结果:CITP组末梢血B淋巴细胞CD40表达率(13.81%±2.98%)明显高于正常对照组(6.31%±1.24%),两者比较差异有统计学意义(P<0.01);CITP组骨髓B淋巴细胞CD40表达率(23.65%±3.25%)也明显高于正常对照组(8.32%±2.34%),两者比较差异亦有统计学意义(P<0.01);CITP患者的外周血B淋巴细胞CD40表达率与PAIgG水平两者间呈显著的正相关(r=0.92,P<0.05)。结论:CD40在CITP患者淋巴细胞的表达异常增高,可能是CITP发病的免疫学机制之一。 Objective:To investigate the effect of costimulatory factors CD40 on the pathogenesis of chronic idi opathic thrombocytopenic purpura (CITP). Method: Expression of CD40 on B lymphocyte of CITP patients' bone marrow and peripheral blood was measured by flow cytometry, and serum PAIgG of CITP patients was measured by ELISA. Result:CD40 expression in B lymphocyte of CITP patients" peripheral blood was obviously higher than that of the control group (13.81%±2.98% vs 6.31%± 1.24%, P〈0.01) ; CD40 expression in B lymphocyte of CITP patients' bone marrow was obviously higher than that of the control group (23.65%±3.25%vs 8.32%±2.34%); CD40 expression in B lymphocyte of CITP patients' peripheral blood had positive correlation with PAIgG ( r=0.92, P〈0.05). Conclusion; CD40 expression in B lymphocyte of CITP patients' bone marrow and peripheral blood significantly increased, this may be one of the immune pathogenesis of CITP.
出处 《临床血液学杂志》 CAS 2006年第5期291-293,共3页 Journal of Clinical Hematology
  • 相关文献

参考文献10

  • 1VAN KOOTEN C,BANCHEREAU J.CD40 -CD40Ligand[J].J Leukoc Biol,2000,67:2-17.
  • 2李玉杰,李幼姬,叶任高,梁柳琴,孔庆瑜,余学清,董秀清.CD40在系统性红斑狼疮外周血淋巴细胞的表达[J].上海免疫学杂志,2003,23(6):407-409. 被引量:5
  • 3KUROIWA T,LEE E G.Cellular interactions in the pathogenesis of lupusnephritis:the role of T cells and macrophages in the amplification of the inflammatory process in the kidney[J].Lupus,1998,7:597 -603.
  • 4JUNE C H,BLUESTONE J A,NADLER L M,et al.The B7 and CD28 Receptor Families[J].Immunol Today,1994,15:321-331.
  • 5HARRIS N L,RONCHESE F.The role of B7 costimulation in T cell immunity[J].Immunol cell boil,1999,77:304-311.
  • 6SCHONBECK U,MACH F,LIPPY P,et al.CD15(CD40ligand)[J].Cell Biol,2000,32:687-693.
  • 7SCHONBECK U,LIPPY P.The CD40/CD154 receptor/ligand[J].Cell Mol Life Sci,2001,58:443-446.
  • 8BURKLY L C.CD40 pathway blockade as an approach to immunotherapy[J].Adv Exp Med Biol,2001,489:135-152.
  • 9刘荷中,毛宁,侯春梅,李秀森,郭子宽,吴英,沈倍奋,唐佩弦.人CD40-Ig融合蛋白在CHO细胞中的表达与纯化研究[J].中华微生物学和免疫学杂志,2001,21(2):151-155. 被引量:2
  • 10王艳华,杨贵贞.CD40反义RNA的构建及其诱导Balm细胞凋亡[J].中国免疫学杂志,1999,15(3):100-102. 被引量:1

二级参考文献12

  • 1金冬雁(译),分子克隆(第2版),1992年,860页
  • 2Bijl M, Horst G, Limburg PC, et al. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus[J]. Ann Rheum Dis, 2001,60 : 523.
  • 3Katsiari CG, Liossis SNC, Dimopoulos AM, et al. CD40L overcxprcssion on T cells and monocytcs from patients with systemic lupus erythematosus is resistant to calcineurin inhlbition[J]. Lupus,2002, 11:370.
  • 4叶任高.系统性红斑狼疮[M].见:叶任高主编.内科学.第5版.北京:人民卫生出版社,2000:909.
  • 5Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients [J]. Arthritis Rheum, 1992,35 : 630.
  • 6Higuchi T, Aiba Y, Nomura T, et al. Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease[J]. J Immunol, 2002, 168 : 9
  • 7Arbuckle MR, James JA, Kohlhase KF, et al. Development of antidsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus[J]. Scand J Immunol, 2001,54:211.
  • 8Crow MK, Kirou KA. Regulation of CD40 ligand expression in systemic lupus erythematosus[J]. Curt Opin Rheumatol,2001,13:361.
  • 9Katsiari C, Liossis S, Souliotis V, et al. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus[J]. Clin Immunol,2002, 103:54.
  • 10刘荷中,凌世淦,陈坤,宋晓国,韩保光,孟莉,马贤凯,董邦权,金伯泉.HIV核心抗原p24检测方法的建立及应用[J].细胞与分子免疫学杂志,1997,13(4):51-54. 被引量:3

共引文献5

同被引文献8

  • 1杨小猛,刘仿,赵丹,陈群,肖红.特发性血小板减少性紫癜患儿血小板数与T细胞凋亡率的相关性分析[J].中华血液学杂志,2004,25(9):559-560. 被引量:7
  • 2Meabed MH, Taha GM, Mohamed SO, et al. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CIM0 on peripheral blood T and B lymphocytes. Hematology, 2007, 12:301-307.
  • 3Perco P, Blaha P, Kainz A, et al. Molecular signature of mice T lymphocytes following tolerance induction by allogeneic BMT and CD40-CD40L costimulation blockade. Transpl Int, 2006, 19 : 146- 157.
  • 4Santos-Argumedo L, Alvarez-Maya I, Romero-Ramirez H, et al. Enforced and prolonged CD40 iigand expression triggers autoantibody production in vivo. Eur J hnmnnol, 2001,31:3484-3492.
  • 5Imadome K, Shimizu N, Arai A, et al. Coexpression of CD40 and CD40 ligand in Epstein-Barr vires-infected T and NK cells and their role in cell survival. J Infect Dis, 2005, 192:1340-1348.
  • 6Lebre MC, Burwell T, Vieira PL, et al. Differential expression of inflammatory chemokines by Th1- and Th2- cell promoting dendritic cells : a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation. hnnmnol Cell Biol, 2005, 83: 525-535.
  • 7Loskog A, Dzojic H, Vikman S, et al. Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor mieroenvironment. J Inmmnol, 2004,172: 7200-7205.
  • 8罗春华,廖清奎,贾苍松.特发性血小板减少性紫癜诊疗建议(修订草案)[J].中国实用儿科杂志,1999,14(7):441-442. 被引量:76

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部